Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.598
-0.012 (-1.90%)
At close: Feb 21, 2025, 4:00 PM
0.609
+0.011 (1.77%)
After-hours: Feb 21, 2025, 5:20 PM EST
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 325 employees as of December 31, 2023. The number of employees decreased by 60 or -15.58% compared to the previous year.
Employees
325
Change (1Y)
-60
Growth (1Y)
-15.58%
Revenue / Employee
$446,883
Profits / Employee
-$235,145
Market Cap
75.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
KPTI News
- 3 days ago - Karyopharm Therapeutics Inc. (KPTI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress - PRNewsWire
- 9 days ago - Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region - PRNewsWire
- 10 days ago - Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 - PRNewsWire
- 19 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives - PRNewsWire
- 7 weeks ago - Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer - PRNewsWire
- 2 months ago - Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications - PRNewsWire